Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Huan Cheng, Jinghua Yu, Chen Yang, Ning Zhang, Zhen Fan, Xiaojuan Zhang, Junchen Wang, Zhen Wang, Da-fang Zhong, Ji-Xiang He, Shu Yan & Xingxing Diao. (2022) Absorption, distribution, metabolism, and excretion of [14C]TPN729 after oral administration to rats. Xenobiotica 52:1, pages 79-90.
Read now
Read now
Luca Boeri, Paolo Capogrosso, Eugenio Ventimiglia, Alessandro Serino, Giovanni La Croce, Andrea Russo, Rocco Damiano, Francesco Montorsi & Andrea Salonia. (2016) Avanafil - a further step to tailoring patient needs and expectations. Expert Review of Clinical Pharmacology 9:9, pages 1171-1181.
Read now
Read now
Albert Haddad, Michel Jabbour & Muhammad Bulbul. (2015) Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive review. Arab Journal of Urology 13:3, pages 155-161.
Read now
Read now
Articles from other publishers (18)
Didem Yilmaz-OralSena F. SezenDamla TurkcanHeba AskerEcem Kaya-SezginerOmer Faruk KirlangicCagla Zubeyde KopruMualla Pınar ElciFatma Zeynep OzenPetek KorkusuzSema OrenCetin Volkan OztekinIlker AtesSerap Gur. (2023) Dual Strategy with Adipose-derived Stem Cells and L-arginine Recovered Cavernosal Functions in a Rat Model of Radical Prostatectomy. Stem Cells and Development.
Crossref
Crossref
Ahmed K. ElHady, Dalia S. El-Gamil, Mohammad Abdel-Halim & Ashraf H. Abadi. (2023) Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives. Pharmaceuticals 16:9, pages 1266.
Crossref
Crossref
D. Menafra, C. de Angelis, F. Garifalos, M. Mazzella, G. Galdiero, M. Piscopo, M. Castoro, N. Verde, C. Pivonello, C. Simeoli, R. S. Auriemma, A. Colao & R. Pivonello. (2022) Long-term high-dose l-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial. Journal of Endocrinological Investigation 45:5, pages 941-961.
Crossref
Crossref
Zhunan Xu, Chu Liu, Shuang Liu & Zhongbao Zhou. (2021) Comparison of efficacy and safety of daily oral L‐arginine and PDE5Is alone or combination in treating erectile dysfunction: A systematic review and meta‐analysis of randomised controlled trials. Andrologia 53:4.
Crossref
Crossref
Luigi Gallo, Stefano Pecoraro, Pasquale Sarnacchiaro, Mauro Silvani & Gabriele Antonini. (2020) The Daily Therapy With L-Arginine 2,500 mg and Tadalafil 5 mg in Combination and in Monotherapy for the Treatment of Erectile Dysfunction: A Prospective, Randomized Multicentre Study. Sexual Medicine 8:2, pages 178-185.
Crossref
Crossref
Matthias Oelke. 2020. Urologic Principles and Practice. Urologic Principles and Practice
127
150
.
Hye Chang Rhim, Min Seo Kim, Young-Jin Park, Woo Suk Choi, Hyoung Keun Park, Hyeong Gon Kim, Aram Kim & Sung Hyun Paick. (2019) The Potential Role of Arginine Supplements on Erectile Dysfunction: A Systemic Review and Meta-Analysis. The Journal of Sexual Medicine 16:2, pages 223-234.
Crossref
Crossref
Smita Pattanaik, Ravimohan S Mavuduru, Arabind Panda, Joseph L Mathew, Mayank M Agarwal, Eu Chang Hwang, Jennifer A Lyon, Shrawan K Singh & Arup K Mandal. (2018) Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia. Cochrane Database of Systematic Reviews 2018:11.
Crossref
Crossref
Jeanne Carter, Shari B. Goldfarb, Yukio Sonoda, Christian J. Nelson, Maura N. Dickler & John P. Mulhall. 2018. The American Cancer Society's Principles of Oncology. The American Cancer Society's Principles of Oncology
359
378
.
Tom MunyerJennifer Elliott. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.
Michelle Herberts, Michael Butcher & Tobias Köhler. (2016) The Effect of LUTS/BPH and Treatments on Ejaculatory Function. Current Urology Reports 17:7.
Crossref
Crossref
Liang Gao, Lu Yang, Shengqiang Qian, Tao Li, Ping Han & Jiuhong Yuan. (2015) Systematic review and meta‐analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction. International Journal of Gynecology & Obstetrics 133:2, pages 139-145.
Crossref
Crossref
Yu-Wen Li, Matthew A. Seager, Trevor Wojcik, Karen Heman, Thaddeus F. Molski, Alda Fernandes, Shaun Langdon, Annapurna Pendri, Samuel Gerritz, Yuan Tian, Yang Hong, Lizbeth Gallagher, James R. Merritt, Chongwu Zhang, Ryan Westphal, Robert Zaczek, John E. Macor, Joanne J. Bronson & Nicholas J. Lodge. (2016) Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy. Neuropharmacology 102, pages 121-135.
Crossref
Crossref
Hüseyin Ede, Serhat Tanik, Barış Yaylak, Kürşad Zengın, Sebahattin Albayrak, Suleyman Akkaya, Cegergun Polat, Yaşar Turan & Alirıza Erbay. (2016) Can Impaired Elasticity of Aorta Predict the Success of Vardenafil Treatment in Patients with Erectile Dysfunction?. Scientifica 2016, pages 1-6.
Crossref
Crossref
M. S. Rahnama’i, R. Hohnen, Ph. E. V. Van Kerrebroeck & G. A. van Koeveringe. (2014) Phosphodiesterase type 2 distribution in the guinea pig urinary bladder. World Journal of Urology 33:10, pages 1623-1633.
Crossref
Crossref
Andrea Salonia, Giulia Castagna & Francesco Montorsi. 2015. Clinical Uro-Andrology. Clinical Uro-Andrology
147
168
.
Ananda T Dias, Bianca P Rodrigues, Marcella L Porto, Agata L Gava, Camille M Balarini, Flavia P S Freitas, Zaira Palomino, Dulce E Casarini, Bianca P Campagnaro, Thiago M C Pereira, Silvana S Meyrelles & Elisardo C Vasquez. (2014) Sildenafil ameliorates oxidative stress and DNA damage in the stenotic kidneys in mice with renovascular hypertension. Journal of Translational Medicine 12:1.
Crossref
Crossref
M. Gacci, M. Carini, M. Salvi, A. Sebastianelli, L. Vignozzi, G. Corona, M. Maggi, K. T. McVary, S. A. Kaplan, M. Oelke & S. Serni. (2014) Management of Benign Prostatic Hyperplasia: Role of Phosphodiesterase-5 Inhibitors. Drugs & Aging 31:6, pages 425-439.
Crossref
Crossref